English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34+ Cells

MPS-Authors
/persons/resource/persons41443

Devanna,  Paolo
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;
Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Centro Cardiologico Monzino, IRCCS, Milan, Italy;

External Resource

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0022158#s5
(Supplementary material)

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

journal.pone.0022158.pdf
(Publisher version), 4MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Burba, I., Colombo, G. I., Staszewsky, L. I., De Simone, M., Devanna, P., Nanni, S., et al. (2011). Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34+ Cells. PLoS One, 6(7): e22158. doi:10.1371/journal.pone.0022158.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-599A-C
Abstract
Use of peripheral blood- or bone marrow-derived progenitors for ischemic heart repair is a feasible option to induce neo-vascularization in ischemic tissues. These cells, named Endothelial Progenitors Cells (EPCs), have been extensively characterized phenotypically and functionally. The clinical efficacy of cardiac repair by EPCs cells remains, however, limited, due to cell autonomous defects as a consequence of risk factors. The devise of “enhancement” strategies has been therefore sought to improve repair ability of these cells and increase the clinical benefit